National Comprehensive Cancer Network



About NCCN

Acute Myeloid Leukemia Panel - Disclosures as of 11/26/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Camille N. Abboud, MD

None

ARIAD Pharmaceuticals, Inc.;
Teva

None

None

None

2/11/2015

Jessica Altman, MD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Genoptix

None

None

None

2/17/2015

Frederick R. Appelbaum, MD

None

None

None

None

None

7/31/2014

Daniel A. Arber, MD

None

US Diagnostic Standards

None

None

None

5/2/2014

Eyal Attar, MD

None

Celgene Corporation;
Jannsen Pharmaceutica Products, LP

None

None

None

2/9/2014

Uma Borate, MD

None

None

None

None

None

1/29/2015

Steven E. Coutre, MD

None

Celgene Corporation

None

None

None

9/16/2014

Lloyd E. Damon, MD

None

None

None

None

None

12/14/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

9/16/2014

Jeffrey Lancet, MD

None

Celgene Corporation;
Spectrum Pharmaceuticals

None

None

None

7/31/2014

Lori J. Maness, MD

Cyclacel, LTD

None

None

None

None

1/7/2014

Guido Marcucci, MD

None

None

None

None

None

8/1/2014

Michael G. Martin, MD

None

None

None

None

None

9/20/2014

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Michael M. Millenson, MD, FACP

None

None

None

None

sanofi-aventis U.S.

1/14/2015

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

2/15/2015

Margaret R. O'Donnell, MD

National Cancer Institute

None

None

None

None

8/6/2014

Daniel A. Pollyea, MD, MS

None

Celgene Corporation;
Agios

None

None

None

1/20/2015

Farhad Ravandi, MD

Bayer HealthCare;
Celgene Corporation;
Merck & Co., Inc.;
Sunesis Pharmaceuticals, Inc.

Bayer HealthCare;
Cephalon, Inc.;
Eisai Inc.;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

None

None

None

12/6/2013

Paul J. Shami, MD

Eisai Inc.;
Genzyme Corporation

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

1/28/2013

B. Douglas Smith, MD

None

ARIAD Pharmaceuticals, Inc.;
Clavis;
TEVA

None

None

None

2/11/2015

Richard M. Stone, MD

Celgene Corporation;
Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

ARIAD Pharmaceuticals, Inc.;
Agios;
Seattle Genetics

None

None

None

7/7/2014

Stephen A. Strickland, MD, MSCI

None

Boehringer Ingelheim GmbH;
Sunesis Pharmaceuticals, Inc.

None

None

None

5/31/2014

Martin S. Tallman, MD

None

Genzyme Corporation

None

None

None

1/7/2014

Sarika Trikha, PharmD

None

None

None

None

None

11/11/2014

Eunice S. Wang, MD

None

None

Incyte

None

None

6/10/2014

Matthew Wieduwilt, MD, PhD

Celgene Corporation;
Pfizer Inc.;
Sigma-Tau Pharmaceuticals, Inc.

None

None

None

None

9/20/2013